PKMYT1 Promotes Gastric Cancer Cell Proliferation and Apoptosis Resistance
ONCOTARGETS AND THERAPY
Authors: Zhang, Qi-Yong; Chen, Xiao-Qin; Liu, Xiong-Chang; Wu, De-Ming
Abstract
Background: Abnormal expression of protein kinase membrane associated tyrosine/threonine 1 (PKMYT1) is closely associated with multiple types of cancers. In the present study, we examined the roles of PKMYT1 in gastric cancer (GC) progression. Methods: We examined the expression status of PKMYT1 in GC tissues and cell lines. Meanwhile, short hairpin RNA (shRNA) was used to inhibit the endogenous expression of PKMYT1 in GC cells. Then we analyzed the effect of PKMYT1 on the malignant biological behavior of GC cells by in vitro and in vivo experiments. Results: The findings showed high PKMYT1 expressions in GC tissues as well as a positive correlation between PKMYT1 expression and prognosis of patients with GC. Additional findings also revealed that PKMYT1 silencing significantly enhanced apoptosis and inhibited GC cell proliferation. In vivo, the silence of PKMYT1 inhibits tumor growth. Further analysis showed that the increase in PKMYT1 expressions led to malignant biological behavior through activation of the MAPK signaling pathway. Conclusion: Our data suggested that PKMYT1 promotes cell proliferation and apoptosis resistance in GC cells by activating the MAPK signaling pathway, making it a potential therapeutic target for GC.
Isoforms of cAMP-dependent protein kinase in the bivalve mollusk Mytilus galloprovincialis: activation by cyclic nucleotides and effect of temperature
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
Authors: Bardales, JR; Diaz-Enrich, MJ; Ibarguren, I; Villamarin, JA
Abstract
Two different isoforms of cAMP-dependent protein kinase (PKA) have been partially purified from the posterior adductor muscle and the mantle tissue of the sea mussel Mytilus galloprovincialis. The holoenzymes contain as regulatory subunit (R) the previously identified isoforms R-myt1 and R-myt2, and were named PKA(myt1) and PKA(myt2), respectively. Both cAMP and cGMP can activate these PKA isoforms completely, although they exhibit a sensitivity approximately 100-fold higher for cAMP than for cGMP. When compared to PKA(myt2), the affinity of PKmyt1 for cAMP and cGMP is 2- and 3.5-fold higher, respectively. The effect of temperature on the protein kinase activity of both PKA isoforms was examined. Temperature changes did not affect significantly the apparent activation constants (K-a) for cANIP. However, the protein kinase activity was clearly modified and a remarkable difference was observed between both PKA isoforms. PKA(myt1) showed a linear Arrhenius plot over the full range of temperature tested, with an activation energy of 15.3 +/- 1.5 kJ/mol. By contrast, PKA(myt2) showed a distinct break in the Arrhenius plot at 15 degreesC the activation energy when temperature was above 15 degreesC was 7-fold higher than that of lower temperatures (70.9 +/- 8.1 kJ/mol vs 10.6 +/- 6.5 kJ/mol). These data indicate that, above 15 degreesC, PKA(myt2) activity is much more temperature-dependent than that of PKA(myt1). This different behavior would be related to the different role that these isoforms may play in the tissues where they are located. (C) 2004 Elsevier Inc. All rights reserved.